Cargando…
Immunotherapy toxicity: identification and management
The widespread adoption of immunotherapy has revolutionized the treatment of various cancer types, including metastatic triple-negative breast cancer (TNBC), which has long been associated with poor prognostic outcomes. In particular, immune checkpoint inhibitors (ICIs) that target and inhibit progr...
Autores principales: | Gumusay, O., Callan, J., Rugo, H. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841316/ https://www.ncbi.nlm.nih.gov/pubmed/35015209 http://dx.doi.org/10.1007/s10549-021-06480-5 |
Ejemplares similares
-
Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy
por: Magbanua, Mark Jesus M., et al.
Publicado: (2022) -
Emerging treatment strategies for metastatic triple-negative breast cancer
por: Huppert, Laura A., et al.
Publicado: (2022) -
The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases
por: Gumusay, Ozge, et al.
Publicado: (2022) -
Management of toxicities associated with novel immunotherapy agents in acute lymphoblastic leukemia
por: Jain, Tania, et al.
Publicado: (2020) -
Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management
por: Simeone, Ester, et al.
Publicado: (2019)